IP Library › Granted Patent US 12,559,777
Granted Patent B2
US 12,559,777 · App. 17/272,803 · Granted Feb 24, 2026

Methods for improving yields of L-glufosinate

Inventors: Brian Michael Green (Lutherville, MD); Danielle Marie Estridge (Lutherville, MD)
Assignee: BASF SE
C12P7/52C12Y206/01C12Y401/01071
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,559,777
App. No.
17/272,803
Granted
Feb 24, 2026
Kind
B2
Abstract

Compositions and methods for the production of L-glufosinate are provided. The method involves converting racemic glufosinate to the L-glufosinate enantiomer or converting PPO to L-glufosinate in an efficient manner. In particular, the method involves the specific amination of PPO to L-glufosinate, using L-glutamate, racemic glutamate, or another amine source as an amine donor. PPO can be obtained by the oxidative deamination of D-glufosinate to PRO (2-oxo-4-(hydroxy (methyl) phosphinoyl) butyric acid) or generated via chemical synthesis. PPO is then converted to L-glufosinate using a transaminase in the presence of an amine donor. When the amine donor donates an amine to PPO. L-glufosinate and a reaction by product are formed. Because the PPO remaining represents a yield loss of L-glufosinate, it is desirable to minimize the amount of PPO remaining in the reaction mixture. Degradation, other chemical modification, extraction, sequestration, binding, or other methods to reduce the effective concentration of the by-product. i.e., the corresponding alpha ketoacid or ketone to the chosen amine donor will shift the reaction equilibrium toward L-glufosinate, thereby reducing the amount of PPO and increasing the yield of L-glufosinate. Therefore, the methods described herein involve the conversion or elimination of the alpha ketoacid or ketone by-product to another product to shift the equilibrium towards L-glufosinate.

Claims (18)

1 . A method for making L-glufosinate, comprising:

reacting D-glufosinate with a D-amino acid oxidase (DAAO) enzyme in the presence of oxygen to form PPO (2-oxo-4-(hydroxy (methyl) phosphinoyl) butyric acid) in an oxidation step;

aminating the PPO by a transaminase (TA) enzyme, using an amine group from one or more amine donors to form L-glufosinate and an alpha ketoacid by-product in an amination step; and

reducing an amount of the alpha ketoacid by-product in a reduction step, wherein more than 90% of the PPO is converted to L-glufosinate,

wherein the DAAO enzyme is a mutant DAAO comprising mutations at positions 54, 56, 58, and 213 using SEQ ID NO:8 as a reference sequence,

wherein the mutations comprise N54V, T56N, F58H, and M213S,

wherein the TA enzyme has the amino acid sequence of SEQ ID NO:7,

wherein the alpha ketoacid by-product is reduced in amount by an addition of ketoglutarate decarboxylase (KGD), and

wherein the reduction of the amount of the alpha ketoacid by-product allows the amination step to proceed at a higher rate than without such reduction and/or reach an equilibrium concentration that results in a higher yield of L-glufosinate than without such reduction.

2 . The method of claim 1 , wherein more than 98% of the PPO is converted to L-glufosinate.

3 . The method of claim 1 , wherein the alpha ketoacid by-product is reduced in amount by enzymatic conversion.

4 . The method of claim 1 , wherein the TA enzyme is a GabT transaminase.

5 . The method of claim 1 , wherein the one or more amine donors comprises glutamate or L-glutamate.

6 . The method of claim 1 , wherein the oxidation, the amination, and the reduction steps are performed in a single container.

7 . The method of claim 1 , wherein all reagents are added at the start of the reaction.

8 . The method of claim 6 , wherein reagents for the oxidation, the amination, and the reduction steps are added to the single container at different times.

9 . The method of claim 1 , wherein the oxidation, the amination, and the reduction steps are performed in separate containers.

10 . The method of claim 1 , wherein the KGD comprises an amino acid sequence selected from SEQ ID NOS: 1, 2, 3, 4, or 5.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2021
From: GREEN, BRIAN MICHAEL; ESTRIDGE, DANIELLE MARIE
To: AGRIMETIS, LLC
Reel/Frame 055460/0194 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2021
From: AGRIMETIS, LLC
To: BASF SE
Reel/Frame 055462/0163 →
Continuity (2)
Provisional Application 62727322 · Sep 5, 2018
Related Publication 20210214754A1 · Jul 15, 2021
References Cited (7)
US 20140371417A1 · Pharkya · 2014 [cited by examiner]
US 20170253897A1 · Green et al. · 2017 [cited by applicant]
Liu, W., et al. 2005 Biochemistry 44(8): 2982-2992. (Year: 2005). [cited by examiner]
Lypetska (Fesko) et al., Investigation of one-enzyme systems in the [omega]-transaminase-catalyzed synthesis of chiral amines, J. Mol. Catalysis B: Enzymatic, 96:103-10 (Dec. 2013). [cited by applicant]
Bartsch et al., Stereospecific production of the herbicide phosphinothricin (glufosinate): purification of aspartate transaminase from [cited by applicant]
Farnberger et al., In vivo plug-and-play: a modular multi-enzyme single-cell catalyst for the asymmetric amination of ketoacids and ketones, Microb. Cell Fact., 16(1):132 (2017). [cited by applicant]
International Application No. PCT/US19/049467, International Search Report and Written Opinion, mailed Dec. 3, 2019. [cited by applicant]